News Sentiment

FLNA sentiment intelligence

Filana Therapeutics, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 20 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.06 Week of 17 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 11

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-10.2% over one week, -13.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Filana Therapeutics (FLNA) Slides 5% as Bearish Momentum Builds; Key Support at $1.04 in Focus - ATR Stop

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction -10.2% Price reacting lower
Trend fit Trend inactive -13.1% over four weeks
Fair value -23.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 16
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 11
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
TradingView 4
dars.gov.et 3
simplywall.st 2
GlobeNewswire 1
MEXC 1
Fierce Pharma 1

Event Lens

What the news is about

Classified themes
Earnings 10
Market update 10

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-20 of 20